These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31356800)

  • 1. Surgery Is Associated With Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis.
    Raman V; Jawitz OK; Voigt SL; Farrow NE; Yang CJ; D'Amico TA; Harpole DH
    Ann Thorac Surg; 2019 Dec; 108(6):1633-1639. PubMed ID: 31356800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.
    Gabriel E; Attwood K; Du W; Tuttle R; Alnaji RM; Nurkin S; Malhotra U; Hochwald SN; Kukar M
    JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?
    Ranney DN; Mulvihill MS; Yerokun BA; Fitch Z; Sun Z; Yang CF; D'Amico TA; Hartwig MG
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):543-551. PubMed ID: 28498967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
    Franko J; Voynov G; Goldman CD
    Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma.
    Marks JL; Hofstetter W; Correa AM; Mehran RJ; Rice D; Roth J; Walsh G; Vaporciyan A; Erasmus J; Chang J; Maru D; Lee JH; Lee J; Ajani JA; Swisher SG
    Ann Thorac Surg; 2012 Oct; 94(4):1126-32; discussion 1132-3. PubMed ID: 22921233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant Chemoradiotherapy.
    Noordman BJ; van Klaveren D; van Berge Henegouwen MI; Wijnhoven BPL; Gisbertz SS; Lagarde SM; van der Gaast A; Hulshof MCCM; Biermann K; Steyerberg EW; van Lanschot JJB;
    Ann Surg; 2018 May; 267(5):892-897. PubMed ID: 28350565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage III esophageal adenocarcinoma: definitive chemoradiation vs. chemoradiation plus surgery.
    Schlottmann F; Strassle PD; Gaber C; Patti MG
    Updates Surg; 2018 Dec; 70(4):423-426. PubMed ID: 29926306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Age on Surgical Outcomes for Locally Advanced Esophageal Cancer.
    Farrow NE; Raman V; Jawitz OK; Voigt SL; Tong BC; Harpole DH; D'Amico TA
    Ann Thorac Surg; 2021 Mar; 111(3):996-1003. PubMed ID: 32853569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Care in Neoadjuvant Chemoradiotherapy for Node-Positive Esophageal Adenocarcinoma.
    Raman V; Jawitz OK; Voigt SL; Rhodin KE; Kim AW; Tong BC; D'Amico TA; Harpole DH
    Ann Thorac Surg; 2020 Dec; 110(6):1832-1839. PubMed ID: 32622794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
    Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
    Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Treatment of T1N0 Esophageal Cancer.
    Semenkovich TR; Hudson JL; Subramanian M; Mullady DK; Meyers BF; Puri V; Kozower BD
    Ann Surg; 2019 Sep; 270(3):434-443. PubMed ID: 31274653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
    Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
    J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology.
    Stiles BM; Kamel MK; Harrison SW; Rahouma M; Lee B; Nasar A; Port JL; Altorki NK
    Ann Thorac Surg; 2019 Jan; 107(1):187-193. PubMed ID: 30278165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.
    Groth SS; Burt BM; Farjah F; Smaglo BG; Sada YH; Sugarbaker DJ; Massarweh NN
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1682-1693.e1. PubMed ID: 30711279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definitive Chemoradiotherapy Compared to Neoadjuvant Chemoradiotherapy With Esophagectomy for Locoregional Esophageal Cancer: National Population-based Cohort Study.
    Kamarajah SK; Phillips AW; Hanna GB; Low D; Markar SR
    Ann Surg; 2022 Mar; 275(3):526-533. PubMed ID: 32865948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
    Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
    Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Modalities for Esophageal Adenocarcinoma in the United States: Trends and Survival Outcomes.
    Di Corpo M; Schlottmann F; Strassle PD; Nurczyk K; Patti MG
    J Laparoendosc Adv Surg Tech A; 2019 Aug; 29(8):989-994. PubMed ID: 31246532
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of surgery in T4N0-3M0 esophageal cancer.
    Qi C; Hu L; Zhang C; Wang K; Qiu B; Yi J; Shen Y
    World J Surg Oncol; 2023 Nov; 21(1):369. PubMed ID: 38008742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran.
    Farhan F; Ghalehtaki R; Mahdavi-Seresht S; Meysamie A; Yamrali M; Farazmand B; Mohammadi N; Saraee E; Mir MR; Mir A; Lashkari M; Salarvand S; Esmati E; Samiei F
    J Gastrointest Cancer; 2019 Dec; 50(4):907-912. PubMed ID: 30402826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.